Identification of a Disease-Associated Network of Intestinal Immune Cells in Treatment-Naive Inflammatory Bowel Disease.
Identification of a Disease-Associated Network of Intestinal Immune Cells in Treatment-Naive Inflammatory Bowel Disease.
复制标题
DOI:
10.3389/fimmu.2022.893803
复制
发表时间:
2022
影响因子:
7.3
通讯作者:
中科院分区:
文献类型:
--
作者:
Chronic intestinal inflammation underlies inflammatory bowel disease (IBD). Previous studies indicated alterations in the cellular immune system; however, it has been challenging to interrogate the role of all immune cell subsets simultaneously. Therefore, we aimed to identify immune cell types associated with inflammation in IBD using high-dimensional mass cytometry. We analyzed 188 intestinal biopsies and paired blood samples of newly-diagnosed, treatment-naive patients (n=42) and controls (n=26) in two independent cohorts. We applied mass cytometry (36-antibody panel) to resolve single cells and analyzed the data with unbiased Hierarchical-SNE. In addition, imaging-mass cytometry (IMC) was performed to reveal the spatial distribution of the immune subsets in the tissue. We identified 44 distinct immune subsets. Correlation network analysis identified a network of inflammation-associated subsets, including HLA-DR+CD38+ EM CD4+ T cells, T regulatory-like cells, PD1+ EM CD8+ T cells, neutrophils, CD27+ TCRγδ cells and NK cells. All disease-associated subsets were validated in a second cohort. This network was abundant in a subset of patients, independent of IBD subtype, severity or intestinal location. Putative disease-associated CD4+ T cells were detectable in blood. Finally, imaging-mass cytometry revealed the spatial colocalization of neutrophils, memory CD4+ T cells and myeloid cells in the inflamed intestine. Our study indicates that a cellular network of both innate and adaptive immune cells colocalizes in inflamed biopsies from a subset of patients. These results contribute to dissecting disease heterogeneity and may guide the development of targeted therapeutics in IBD.
登录
查看更多内容
影响因子:
15.3
作者:
Yu, D T;Winchester, R J;Fu, S M;Gibofsky, A;Ko, H S;Kunkel, H G
通讯作者:
Kunkel, H G
影响因子:
64.5
作者:
Kinchen J;Chen HH;Parikh K;Antanaviciute A;Jagielowicz M;Fawkner-Corbett D;Ashley N;Cubitt L;Mellado-Gomez E;Attar M;Sharma E;Wills Q;Bowden R;Richter FC;Ahern D;Puri KD;Henault J;Gervais F;Koohy H;Simmons A
通讯作者:
Simmons A
影响因子:
29.4
作者:
Mitsialis V;Wall S;Liu P;Ordovas-Montanes J;Parmet T;Vukovic M;Spencer D;Field M;McCourt C;Toothaker J;Bousvaros A;Boston Children’s Hospital Inflammatory Bowel Disease Center;Brigham and Women’s Hospital Crohn’s and Colitis Center;Shalek AK;Kean L;Horwitz B;Goldsmith J;Tseng G;Snapper SB;Konnikova L
通讯作者:
Konnikova L
影响因子:
3.7
作者:
Abdelaal, Tamim;van Unen, Vincent;Mahfouz, Ahmed
通讯作者:
Mahfouz, Ahmed
影响因子:
64.5
作者:
Martin, Jerome C.;Chang, Christie;Kenigsberg, Ephraim
通讯作者:
Kenigsberg, Ephraim